U-Chart Analysis:WAKAMOTO PHARMACEUTICAL CO.,LTD.:4512

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index WAKAMOTO PHARMACEUTICAL CO.,LTD. Go to web site 4512 Medicals 東証スタンダード March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2025年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents 2,955 3,665 3,879 3,232 2,844
Other Current AssetsHelp 5,953 5,305 5,474 5,376 4,794
Tangible Fixed AssetsHelp 3,313 3,028 3,032 3,297 3,527
Intangible Fixed AssetHelp 278 357 202 196 201
Investments and OthersHelp 2,503 3,066 3,124 2,852 3,207
Total AssetsHelp 15,003 15,421 15,712 14,953 14,572
Total Current LiabilitiesHelp 3,392 3,395 3,804 3,471 3,184
Total Long-term LiabilitiesHelp 0 0 1 2 3
Shareholder's EquityHelp 11,610 12,026 11,907 11,481 11,386
Total LiabilitiesHelp 15,003 15,421 15,712 14,953 14,572

WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2025年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales 7,789 7,738 8,660 8,383 8,896
Total Sales 7,789 7,738 8,660 8,383 8,896
Cost of SalesHelp 4,167 4,139 4,552 4,027 4,407
Other Costs and RevenueHelp 3,558 3,491 3,970 4,117 5,091
Total CostsHelp 7,725 7,629 8,522 8,145 9,498
Net RevenueHelp 3,622 3,600 4,108 4,356 4,489
Earnings Before TaxHelp 7 159 212 285 -703
Net IncomeHelp 64 109 138 239 -602
Net Income 64 109 138 239 -602

WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2025年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help -592 -107 632 339 163
Investing Cash Flow(ICF)Help -13 -2 17 51 -200
Financing Cash FlowHelp -104 -105 -2 -2 -4
Exchange Difference of Cash and Cash EquivalentsHelp 0 0 0 -0 0
Net Increase and Decrease in Cash and Cash Equivalentsn -710 -215 647 388 -40

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

WAKAMOTO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

Fuji Pharma Co.,Ltd.
ASKA Pharmaceutical Co.,Ltd.
OncoTherapy Science,Inc.
Delta-Fly Pharma,Inc.
KAINOS Laboratories,Inc.
Kyowa Kirin Co.,Ltd.
PRISM BioLab
NANO MRNA Co., Ltd.
Heartseed
DAIICHI SANKYO COMPANY, LIMITED